Cushing's syndrome is a heterogeneous disorder characterized by numerous physical, psychological and metabolic abnormalities associated with glucocorticoid excess. Left untreated, the condition is associated with considerable morbidity and mortality. 1 The importance of accurate diagnosis and treatment can be inferred from the improved outcome following intervention. However, some individuals do not conform to traditional investigative approaches, presenting a diagnostic trap for the unwary. During the last decade, the condition of`subclinical' or`preclinical' Cushing's syndrome has been described, 2±4 in which hypercortisolism due to an adrenal adenoma exists in the absence of clinical features of Cushing's syndrome. Furthermore, the glucocorticoid excess may coexist with normal or low±normal concentrations of adrenocorticotrophin (ACTH), which may cause confusion in making an accurate diagnosis. 2±4 Also, reports have shown that cortisol concentrations may be suppressed in pituitary-dependent
Cushing's disease after low-dose dexamethasone testing. 5, 6 Such anomalies make the accurate diagnosis of Cushing's syndrome particularly dif®cult in certain cases.
CASE 1
A 52-year-old female was admitted with a 1-year history of hypertension, depression and general malaise. Her past medical history was otherwise uneventful; there had been no weight gain and she had undergone the menopause 3 years previously. She was taking amlodipine 5 mg daily, together with combined transdermal oestrogen and oral norethisterone. On examination, her blood pressure was 170/100, but there were no physical features whatsoever to suggest Cushing's syndrome. Investigations demonstrated a hypokalaemia of 2´6 mmol/L, a high bicarbonate of 31´3 mmol/L with normal plasma glucose of 4´6 mmol/L. Primary hyperaldoster-onism was suspected but both recumbent and ambulant plasma renin activities and aldosterone concentrations were appropriately suppressed. Urinary free cortisol estimates and urinary catecholamines were normal on two separate occasions. Cortisol and ACTH concentrations at 9 a.m. and midnight are shown in Table 1 and reveal high cortisol concentrations with detectable ACTH. Magnetic resonance imaging (MRI) of the adrenals revealed a 3´5 cm lesion of the right adrenal gland. There was inadequate suppression of an 8 a.m. plasma cortisol after 1 mg of overnight dexamethasone (136 nmol/L) and after low-dose (0´5 mg q.d.s. for 48 h) and high-dose (2 mg q.d.s. for 48 h) dexamethasone suppression testing with results of 90 and 106 nmol/L, respectively ( Table 1 ).
In view of the non-suppressible cortisol concentrations after dexamethasone, together with detectable ACTH concentrations, pituitary-dependent Cushing's syndrome was considered, although MRI of the pituitary was normal. Selenocholesterol scanning with dexamethasone revealed high tracer uptake in the right adrenal with suppressed uptake on the left. Due to the low-normal ACTH concentrations and the presence of a functional adrenal adenoma, as well as the absence of any physical features of hypercortisolism, the diagnosis was considered to be subclinical Cushing's syndrome. A laparoscopic right adrenalectomy was performed and histology con®rmed an adrenocortical adenoma.
Postoperatively, the patient did not require exogenous glucocorticoids, and a short synacthen test (250 mg i.v.) demonstrated serum cortisol concentrations of 295 nmol/L basally and 554 nmol/L at 30 min, re¯ecting an adequate adrenal reserve. Also, urinary free cortisol estimates remained within the normal range and serum cortisol concentrations suppressed appropriately to 10 nmol/L after the 1 mg overnight dexamethasone suppression test. Three months after surgery, the patient was well, plasma electrolyes were all normal and her hypertension had resolved to 130/85 without antihypertensives.
CASE 2
A 36-year-old male was referred with suspected Cushing's syndrome. Over the previous 3 years he had been aware of a gradual change in facial appearance, abdominal striae, increasing obesity, reduced libido and depression. On examination he was noted to be cushingoid, with a rounded plethoric complexion, marked abdominal striae and mild proximal myopathy affecting the upper and lower limbs. His blood pressure was 140/85. Urea and electrolytes were normal, with a plasma glucose of 4´2 mmol/L and HbA 1c of 5´3%. He had hypogonadotrophic hypogonadism, with a testosterone of 5´3 nmol/L (normal range [NR]: 12±21), luteinizing hormone (LH) of 2´4 mU/L (NR: 1´9±12´5) and follicle-stimulating hormone (FSH) of 3´3 mU/L (NR: 2´5±9´1). Thyroid function was normal. Urinary free cortisol estimates were persistently elevated on three separate occasions with levels around 1000 nmoL/24 h (NR: <290 nmol/24 h). Nine a.m. and midnight cortisol and ACTH concentrations are illustrated in Table 1 , together with results of dexamethasone suppression testing. These reveal a lack of diurnal variation of cortisol with ACTH concentrations in the normal range but entirely appropriate suppression of serum cortisol concentrations after low-dose dexamethasone (15 nmol/L). Pituitary MRI did not reveal any discrete lesion and computed tomography (CT) imaging of the adrenals was normal. In order to con®rm the suspected diagnosis of pituitary-dependent Cushing's disease, the low-dose dexamethasone test was repeated, and 1 h after the test was completed the patient received 100 mg of ovine corticotropin-releasing factor (CRF). Following repeat low-dose dexamethasone the cortisol concentration was again appropriately suppressed at 18 nmol/L but rose to 138 nmol/L 15 min after CRF stimulation, con®rming the diagnosis. 7 A transphenoidal right hemihypophysectomy was performed and the histology revealed a 0´3 mm corticotroph adenoma. Postoperatively, cortisol concentrations were undetectable (<10 nmol/L), with persisting hypogonadotrophic hypogonadism, secondary hypothyroidism and growth hormone de®ciency con®rmed by growth hormone releasing hormone (GHRH)±arginine testing. Currently, the patient feels much improved with resolution of his cushingoid features and is treated with growth hormone 1´5 IU/day, hydrocortisone 10 mg b.d., thyroxine 100 mg/day and testosterone 250 mg i.m. monthly.
LABORATORY METHODS
HbA 1c was measured by cation exchange highperformance liquid chromatography following blood sample haemolysis in a tetrapolyphosphate buffer. Following chromatographic separation, HbA 1c and total Hb were measured spectrophotometrically (A Merrarini Diagnostics Ltd, Wokingham, UK). The non-diabetic reference range for individuals less than 40 years old is between 4% and 6%. The coef®cient of variation at 5´8% is 1´6 and at 9´5% is 0´8.
After prior extraction of urine using dichloromethane, both urinary free cortisol and serum cortisol were measured by an immunochemiluminometric assay using a Bayer ACS:180 automated analyser (Bayer Diagnostics, Halstead, UK). The between-assay imprecision at mean urine free cortisol concentrations of 39 and 339 nmol/24 h was 28´6% and 6´7%, respectively, and at mean serum cortisol concentrations of 150 and 473 nmol/L was 6´5% and 6´1%, respectively. ACTH concentrations were measured by an immunochemiluminometric assay using an acridinium ester as label (Nichols Institute Diagnostics, San Juan Capistrano, CA, USA). The between-assay imprecision at mean ACTH concentrations of 38 and 352 ng/L was 5´9% and 6´6%, respectively.
DISCUSSION
These two cases illustrate the highly diverse presentations of Cushing's syndrome and the dif®culties in establishing the exact diagnosis. The ®rst case reveals the nuances of subclinical Cushing's syndrome with hypercortisolism due to a functional adrenal adenoma but low± normal ACTH concentrations, in the absence of overt features of Cushing's syndrome. Sporadic case reports have emerged over the last decade illustrating the lack of suppression of cortisol after both low-and high-dose dexamethasone testing in incidentally discovered adrenal adenomas otherwise considered to be non-functional. 2±4 In the absence of any clinical features of hypercortisolism, the clinical complex was termed preclinical or subclinical Cushing's syndrome. With the more widespread use of imaging techniques, adrenal adenomas are increasingly being detected coincidentally. 8 Consequently, it is believed that some adrenal adenomas are being detected at an early stage in their transition to fully autonomous adrenal adenomas in which the full features of Cushing's syndrome are obvious. Accordingly, the early adenoma produces cortisol semi-autonomously, suf®cient to reduce, but not entirely suppress, ACTH secretion. With increasing adenoma cell number and tumour enlargement, autonomous cortisol secretion increases, ACTH becomes increasingly suppressed and clinical features start to evolve. 9±11 Such an hypothesis is supported by recent observations showing that post-low-dose dexamethasone cortisol concentrations are inversely related to ACTH concentrations and directly related to tumour size. 12, 13 Until recently, subclinical Cushing's syndrome was considered to be rare; however, recent studies have suggested that it may be apparent in up to 15% of adrenal adenomas. 13 Confusion may exist in distinguishing between subclinical Cushing's syndrome caused by an adrenal adenoma and pituitary-dependent Cushing's syndrome due to detectable ACTH concentrations. However, the absence of clinical features makes the diagnosis of subclinical Cushing's syndrome far more likely, although pituitary-dependent Cushing's syndrome has also been described without clinical features. 14 Accordingly, scintigraphic studies may prove a useful discriminant, 15 localizing the lesion and providing information on the functional autonomy of the adenoma. 15, 16 Unlike pituitarydependent Cushing's syndrome, low dehydroepiandrosterone sulphate concentrations have also been demonstrated in association with functional adrenocortical adenomas. 12 It is assumed that subclinical Cushing's syndrome represents one of the earliest stages in the progression of the adrenal adenoma to overt Cushing's syndrome, but the natural history of such functional adrenal adenomas is not fully appreciated. Although clinical signs are absent, hypertension, hyperglycaemia and weight gain are reported in association with subclinical Cushing's syndrome and may improve following surgery. 17±20 Our ®rst patient (case 1) was hypertensive and hypokalaemic, both features resolving after surgery. Hypertension is frequently associated with Cushing's syndrome, being apparent in approximately 80% of sufferers, although the rate of hypokalaemia varies depending upon the aetiology and is most commonly associated with ectopic ACTH secretion. 1 Furthermore, reduced bone mineralization 19, 21 and adverse lipid pro®les 13 may also feature. Therefore, the condition may not be as`subclinical' as the name would suggest, and, in view of the above and with reduced morbidity-associated with laparoscopic surgery, earlier intervention may be desirable. Also, surgical excision of an adrenal adenoma larger than 3 cm in diameter is favoured 22 because of the possibility of occult malignancy. 23 Postoperatively, it is important to consider that hypoadrenalism may ensue 11, 24 , and death due to acute hypoadrenalism has been reported. 11 However, as our case 1 illustrates, eucortisolism was restored postoperatively, as demonstrated by the normal response to the short synacthen test and appropriate suppression with the 1 mg overnight dexamethasone test.
The second case illustrates the sharply contrasting scenario of a patient with a very high clinical suspicion of Cushing's syndrome yet normal suppression of cortisol following lowdose dexamethasone testing, suggesting a diagnosis of pseudo-Cushing's. However, there are a small number of case reports of con®rmed pituitary-dependent Cushing's disease with appropriate suppression of cortisol after lowdose dexamethasone. 5, 6 Although the exact mechanism is not entirely understood, it may be due to reduced hepatic dexamethasone clearance with resultant elevations of plasma dexamethasone concentrations. Recently, Yanovski et al. 7 demonstrated that the low-dose dexamethasone test followed by CRF stimulation could be used to discriminate between patients with pituitary-derived Cushing's disease and pseudo-Cushing's. Following completion of a low-dose dexamethasone test, 100 mg of ovine CRF is given and serum cortisol is measured 15 min later. They suggested that a serum cortisol level greater than 38 nmol/L after this combined test accurately identi®ed those with pituitary-derived Cushing's disease. 7 This test would be unnecessary in the majority of patients with pituitary-derived Cushing's disease whose plasma cortisol concentrations are not suppressed below 38 nmol/L following low-dose dexamethasone. Therefore, the test could be reserved for those patients in whom there is a high index of suspicion of Cushing's syndrome yet appropriate suppression of cortisol.
In conclusion, both cases demonstrate the complexities of accurately diagnosing Cushing's syndrome. The ®rst case illustrates the recently recognized yet little understood concept of subclinical Cushing's syndrome. The second case illustrates the rarely reported phenomenon of pituitary-dependent Cushing's syndrome with normal suppression of cortisol concentrations following low-dose dexamethasone. These cases reveal the considerable dif®culties in establishing an accurate diagnosis in Cushing's syndrome and show the diagnostic traps which may befall the unwary.
